Main menu button

Equity Research Svenska Aerogel, Q1 2024: Streamlining to reduce costs

8 May 2024

Svenska Aerogel Holding AB’s sales in Q1 2024 came in lower than our expectations. Although sales fell below expectations, the Company’s initiation of a significant efficiency program in Q1 is a positive development, promising cost savings. Also, positive progress has been achieved regarding customer collaborations.

Weak sales in Q1 2024, but efficiency improvements to boost margins

In Q1 2024, Svenska Aerogel reported sales just above SEK 0.5 million, significantly lower than our projected SEK 1.5 million. Consequently, both EBITDA and EBIT fell well below our expectations due to the reduced turnover. EBITDA came in at minus SEK 8.9 million compared to our forecast of minus SEK 7.0 million, while EBIT was minus SEK 10.8 million against our forecast of minus SEK 9.0 million. This departure from the trend seen in Q4 2023, where sales and profitability aligned with our forecasts, did not carry over into Q1 2024. However, the company has recently initiated an efficiency program to generate savings of slightly over SEK 10 million over the next 12 months. This program impacts the entire cost structure, including the cost of goods sold, and is expected to yield improved margins, primarily from Q3 2024 onward.

So far in 2024, the Company has received a framework order for 3 tons of Quartzene® from the French distributor Novcoat. This order, scheduled for delivery throughout the year, is valued at 96.8 kEUR, equivalent to around SEK 1.1 million. Additionally, the Company has obtained two significant pilot orders: one from a leading player in the electric vehicle battery industry, set to integrate Quartzene® into their product by Q2 2024, and another from a new client in the process industry employing Quartzene® for thermal insulation. Together, these orders total approximately 700 kg of Quartzene®. Financially, the Company recently bolstered its position with a gross influx of approximately SEK 51 million from a recent rights issue, part of which was allocated to the early repayment of a SEK 10 million convertible loan. This repayment translates into reduced interest expenses. As of March 31, 2024, the Company held around SEK 27 million in cash.


Carlsquare AB,, hereinafter referred to as Carlsquare, is engaged in corporate finance and equity research, publishing information on companies and including analyses. The information has been compiled from sources that Carlsquare deems reliable. However, Carlsquare cannot guarantee the accuracy of the information. Nothing written in the analysis should be considered a recommendation or solicitation to invest in any financial instrument, option, or the like. Opinions and conclusions expressed in the analysis are intended solely for the recipient.

The content may not be copied, reproduced, or distributed to any other person without the written consent of Carlsquare. Carlsquare shall not be liable for either direct or indirect damages caused by decisions made on the basis of information contained in this analysis. Investments in financial instruments offer the potential for appreciation and gains. All such investments are also subject to risks. The risks vary between different types of financial instruments and combinations thereof. Past performance should not be taken as an indication of future returns.

The analysis is not directed at U.S. Persons (as that term is defined in Regulation S under the United States Securities Act and interpreted in the United States Investment Companies Act of 1940), nor may it be disseminated to such persons. The analysis is not di-rected at natural or legal persons where the distribution of the analysis to such persons would involve or entail a risk of violation of Swedish or foreign laws or regulations.

The analysis is a so-called Assignment Analysis for which the analysed company has signed an agreement with Carlsquare for analysis coverage. The analyses are published on an ongoing basis during the contract period and for the usually fixed fee. Carlsquare may or may not have a financial interest with respect to the subject matter of this analysis. Carlsquare values the assurance of objectivity and independence and has established procedures for managing conflicts of interest for this purpose.

The analysts Christopher Solbakke and Bertil Nilsson do not own and may not own shares in the analysed company.

Equity Research Svenska Aerogel, Q1 2024: Streamlining to reduce costs